MedTrace Logo

Bowel Dysfunction After Rectal Cancer Treatment

NCT05020132 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2023-09-28

No results posted yet for this study

Summary

Bowel dysfunction after rectal cancer treatment may significantly affect the quality of life. Our study aimed to estimate the incidence and characterize the Low Anterior Resection Syndrome(LARS). We performed a prospective evaluation of patients treated with anterior resection for rectal cancer at two hospitals. Assessment was performed at baseline, after neoadjuvant treatment, and 1, 6 and 12 months after bowel transit reconstruction using the following scores: Bristol scale, LARS score, MSK-BFI, FIQL, EORTC-QLQ30 and a visual analogue scale.

Conditions

  • Low Anterior Resection Syndrome

Sponsors & Collaborators

  • Hospital Universitari MútuaTerrassa

    collaborator UNKNOWN

  • Consorci Sanitari de Terrassa

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-01
Primary Completion
2018-09-30
Completion
2020-09-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05020132 on ClinicalTrials.gov